RETINA
DEAD

Serial Number

78258868

Owner

PrimaGen Holding B. V.

Attorney

Michael B. Lasky

Filing Date

Jun 5, 2003

Add to watchlist:

No watchlists yet
View on USPTO

RETINA Trademark

Serial Number: 78258868 • Registration: 3072721

RETINA is a trademark filed by PrimaGen Holding B. V. on June 5, 2003. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently no longer active.

Owner Contact Info

PrimaGen Holding B. V. (4 trademarks)

Meibergdreef 59
1105 BA Amsterdam , NL

Entity Type: 10

Trademark Details

Filing Date

June 5, 2003

Registration Date

March 28, 2006

Published for Opposition

January 3, 2006

Cancellation Date

November 2, 2012

Goods & Services

Diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology, namely molecular diagnostic kits used to generate a clinical or scientific result by amplification and / or detection of DNA or RNA sequences in tissues, body fluids and/or cells of human or animal origin, specifically in the field of HIV and other virus detection, mitochondrical function and / or toxicity, and for tumor markers; medical diagnostic reagents; kits for DNA and RNA analysis comprised primarily of chemical reagents for clinical or medical laboratory use, all specifically in the field of HIV and other virus detection, mitochondrical function and/or toxicity and for tumor markers

Diagnostic preparations and reagents for scientific or research use; chemical and biochemical reagents for scientific RNA and DNA research use; kits for DNA and RNA analysis comprised primarily of chemical reagents for scientific or research use, all specifically in the field of HIV and other virus detection, mitochondrical function and/or toxicity and for tumor markers

Medical and veterinary diagnostic apparatus and instruments to be used with molecular diagnostic kits used to generate a clinical or scientific result by amplification and/or detection of DNA or RNA sequences in tissues, body fluids and / or cells of human or animal origin, specifically in the field of HIV and other virus detection, mitochondrical function and / or toxicity, and for tumor markers

Filing History

CANCELLED SEC. 8 (6-YR)
Nov 2, 2012 C8..
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 5, 2008 TCCA
REGISTERED-PRINCIPAL REGISTER
Mar 28, 2006 R.PR
ASSIGNED TO EXAMINER
Feb 14, 2006 DOCK
PUBLISHED FOR OPPOSITION
Jan 3, 2006 PUBO
NOTICE OF PUBLICATION
Dec 14, 2005 NPUB
LAW OFFICE PUBLICATION REVIEW COMPLETED
Nov 15, 2005 PREV
ASSIGNED TO LIE
Nov 4, 2005 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 31, 2005 CNSA
AMENDMENT FROM APPLICANT ENTERED
Aug 4, 2005 ACEC
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 10, 2005 CRFA
PAPER RECEIVED
Mar 10, 2005 MAIL
NON-FINAL ACTION E-MAILED
Jan 14, 2005 GNRT
NON-FINAL ACTION WRITTEN
Jan 14, 2005 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 4, 2005 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 20, 2004 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 20, 2004 TROA
FINAL REFUSAL E-MAILED
Jul 1, 2004 GNFR
Sec. 1(B) CLAIM DELETED
May 21, 2004 1.BD
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 21, 2004 CRFA
PAPER RECEIVED
May 21, 2004 MAIL
NON-FINAL ACTION E-MAILED
Nov 21, 2003 GNRT
ASSIGNED TO EXAMINER
Nov 20, 2003 DOCK